推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER CELL

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER CELL最新评论:大佬 cell press是美国的 (2024-03-14)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CANCER CELL期刊基本信息Hello,您是该期刊的第102906位访客

基本信息 登录收藏
期刊名字CANCER CELLCANCER CELL

CANCER CELL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
9.8
51人评分
我要评分

声誉
10.0

影响力
9.7

速度
9.4

期刊ISSN1535-6108
微信扫码收藏此期刊
E-ISSN1878-3686
2022-2023最新影响因子
(数据来源于搜索引擎)
50.3 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:36.292
2022-2023自引率1.20%点击查看自引率趋势图
五年影响因子43.9
h-index 295
CiteScore
CiteScoreSJRSNIPCiteScore排名
52.9012.5785.274
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q13 / 214
大类:Biochemistry, Genetics and Molecular Biology
小类:Oncology
Q17 / 366

期刊简介Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. The primary criterion for considering manuscripts is whether the studies provide major advances into answering important questions relevant to naturally occurring cancers. Cancer Cell particularly welcomes translational research. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.
期刊官方网站http://www.cell.com/cancer-cell/home
期刊投稿网址https://www.editorialmanager.com/CANCER-CELL
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER CELL的语言要求,还能让CANCER CELL编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER CELL编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式CELL PRESS, 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, USA, MA, 02139
出版商Cell Press
涉及的研究方向医学-肿瘤学
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份2002
年文章数 80点击查看年文章数趋势图
Gold OA文章占比17.12%
研究类文章占比:
文章 ÷(文章 + 综述)
95.00%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:CELL BIOLOGY
类别:SCIE
Q14/191
学科:ONCOLOGY
类别:SCIE
Q16/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区3区
CELL BIOLOGY
细胞生物学
1区1区1区
ONCOLOGY
肿瘤学
2区4区1区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区4区
CELL BIOLOGY
细胞生物学
3区4区1区
ONCOLOGY
肿瘤学
1区3区1区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区3区
CELL BIOLOGY
细胞生物学
4区1区1区
ONCOLOGY
肿瘤学
3区4区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-6108%5BISSN%5D
平均审稿速度网友分享经验:
偏慢,4-8周
平均录用比例网友分享经验:
极难
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER CELL顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CANCER CELL期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER CELL中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER CELL上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    Nature Reviews Clinical Oncology12775.50
    NATURE REVIEWS CANCER39696.70
    LANCET ONCOLOGY27462.00
    ANNALS OF ONCOLOGY21063.00
    JOURNAL OF CLINICAL ONCOLOGY49439.60
    SEMINARS IN CANCER BIOLOGY13420.00
    CANCER TREATMENT REVIEWS11620.70
    CLINICAL CANCER RESEARCH29221.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6720.70
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE596513
    BIOMATERIALS510019
    BIOMEDICINE & PHARMACOTHERAPY457750
    Journal of Materials Chemistry B456106
    Frontiers in Pharmacology445089
    Frontiers in Immunology415539
    COLLOIDS AND SURFACES B-BIOINTERFACES401295
    JOURNAL OF ETHNOPHARMACOLOGY400451
    Frontiers in Oncology380023
    Acta Biomaterialia372286
  •  

    CANCER CELL CANCER CELL
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer

    Author: Teng, Huajing; Wang, Yan; Sui, Xin; Fan, Jiawen; Li, Shuai; Lei, Xiao; Shi, Chen; Sun, Wei; Song, Maxiaowei; Wang, Hongzhi; Dong, Dezuo; Geng, Jianhao; Zhang, Yangzi; Zhu, Xianggao; Cai, Yong; Li, Yongheng; Li, Bo; Min, Qingjie; Wang, Weihu; Zhan, Qimin
    Journal: CANCER CELL. 2023; Vol. 41, Issue 1, pp. 124-+. DOI: 10.1016/j.ccell.2022.11.013
        PubMed      DOI
    2.A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK

    Author: Xiaodong Feng, Nadia Arang, Damiano Cosimo Rigiracciolo, Joo Sang Lee, Huwate Yeerna, Zhiyong Wang, Simone Lubrano, Ayush Kishore, Jonathan A. Pachter, Gabriele M. König, Marcello Maggiolini, Evi Kostenis, David D. Schlaepfer, Pablo Tamayo, Qianming Chen, Eytan Ruppin, J. Silvio Gutkind
    Journal: CANCER CELL, 2019, Vol.35, 457-472.e5, DOI:10.1016/j.ccell.2019.01.009
        DOI
    3.Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation

    Author: Jinchul Kim, Lili Yu, Wancheng Chen, Yanxia Xu, Meng Wu, Dilyana Todorova, Qingshuang Tang, Bingbing Feng, Lei Jiang, Jingjin He, Guihua Chen, Xuemei Fu, Yang Xu
    Journal: CANCER CELL, 2019, Vol.35, 191-203.e8, DOI:10.1016/j.ccell.2018.12.012
        DOI
    4.CHAF1B Overexpression: A Brake for the Differentiation of Leukemia Cells

    Author: Qing Li, Xu Zhang, Zhiguo Zhang
    Journal: CANCER CELL, 2018, Vol.34, 693-694, DOI:10.1016/j.ccell.2018.10.011
        DOI
    5.Characteristics and Significance of the Pre-metastatic Niche

    Author: Yang Liu, Xuetao Cao
    Journal: CANCER CELL, 2016, Vol.30, 668-681, DOI:10.1016/j.ccell.2016.09.011
        DOI
    6.FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis

    Author: Lin Shan, Xing Zhou, Xinhua Liu, Yue Wang, Dongxue Su, Yongqiang Hou, Na Yu, Chao Yang, Beibei Liu, Jie Gao, Yang Duan, Jianguo Yang, Wanjin Li, Jing Liang, Luyang Sun, Kexin Chen, Chenghao Xuan, Lei Shi, Yan Wang, Yongfeng Shang
    Journal: CANCER CELL, 2016, Vol.30, 708-722, DOI:10.1016/j.ccell.2016.09.010
        DOI
    7.Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential

    Author: Wen-Lian Chen, Yue-Ying Wang, Aihua Zhao, Li Xia, Guoxiang Xie, Mingming Su, Linjing Zhao, Jiajian Liu, Chun Qu, Runmin Wei, Cynthia Rajani, Yan Ni, Zhen Cheng, Zhu Chen, Sai-Juan Chen, Wei Jia
    Journal: CANCER CELL, 2016, Vol.30, 779-791, DOI:10.1016/j.ccell.2016.09.006
        DOI
    8.Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer

    Author: Hanlin Zeng, Jia Qu, Nan Jin, Jun Xu, Chenchu Lin, Yi Chen, Xinying Yang, Xiang He, Shuai Tang, Xiaojing Lan, Xiaotong Yang, Ziqi Chen, Min Huang, Jian Ding, Meiyu Geng
    Journal: CANCER CELL, 2016, Vol.30, 459-473, DOI:10.1016/j.ccell.2016.08.001
        DOI
    9.GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis

    Author: Qing-Hai Ye, Wen-Wei Zhu, Ju-Bo Zhang, Yi Qin, Ming Lu, Guo-Ling Lin, Lei Guo, Bo Zhang, Zhen-Hai Lin, Stephanie Roessler, Marshonna Forgues, Hu-Liang Jia, Lu Lu, Xiao-Fei Zhang, Bao-Feng Lian, Lu Xie, Qiong-Zhu Dong, Zhao-You Tang, Xin Wei Wang, Lun-Xiu Qin
    Journal: CANCER CELL, 2016, Vol.30, 444-458, DOI:10.1016/j.ccell.2016.07.017
        DOI
    10.Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils

    Author: Yanfang Liu, Yan Gu, Yanmei Han, Qian Zhang, Zhengping Jiang, Xiang Zhang, Bo Huang, Xiaoqing Xu, Jianming Zheng, Xuetao Cao
    Journal: CANCER CELL, 2016, Vol.30, 243-256, DOI:10.1016/j.ccell.2016.06.021
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共45条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451